| A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking CE Teunissen, A Petzold, JL Bennett, FS Berven, L Brundin, M Comabella, ... Neurology 73 (22), 1914-1922, 2009 | 764 | 2009 |
| Association of initial disease-modifying therapy with later conversion to secondary progressive multiple sclerosis JWL Brown, A Coles, D Horakova, E Havrdova, G Izquierdo, A Prat, ... Jama 321 (2), 175-187, 2019 | 503 | 2019 |
| Defining secondary progressive multiple sclerosis J Lorscheider, K Buzzard, V Jokubaitis, T Spelman, E Havrdova, ... Brain 139 (9), 2395-2405, 2016 | 427 | 2016 |
| Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study A He, B Merkel, JWL Brown, LZ Ryerson, I Kister, CB Malpas, S Sharmin, ... The Lancet Neurology 19 (4), 307-316, 2020 | 320 | 2020 |
| Characterization of the murine alpha interferon gene family V Van Pesch, H Lanaya, JC Renauld, T Michiels Journal of virology 78 (15), 8219-8228, 2004 | 279 | 2004 |
| Geographical variations in sex ratio trends over time in multiple sclerosis M Trojano, G Lucchese, G Graziano, BV Taylor, S Simpson Jr, V Lepore, ... PloS one 7 (10), e48078, 2012 | 273 | 2012 |
| A basic overview of multiple sclerosis immunopathology N Grigoriadis, V Van Pesch European journal of neurology 22, 3-13, 2015 | 262 | 2015 |
| Predictors of long‐term disability accrual in relapse‐onset multiple sclerosis VG Jokubaitis, T Spelman, T Kalincik, J Lorscheider, E Havrdova, ... Annals of neurology 80 (1), 89-100, 2016 | 216 | 2016 |
| Defining reliable disability outcomes in multiple sclerosis T Kalincik, G Cutter, T Spelman, V Jokubaitis, E Havrdova, D Horakova, ... Brain 138 (11), 3287-3298, 2015 | 215 | 2015 |
| Predictors and dynamics of postpartum relapses in women with multiple sclerosis SE Hughes, T Spelman, OM Gray, C Boz, M Trojano, A Lugaresi, ... Multiple Sclerosis Journal 20 (6), 739-746, 2014 | 215 | 2014 |
| Sex as a determinant of relapse incidence and progressive course of multiple sclerosis T Kalincik, V Vivek, V Jokubaitis, J Lechner-Scott, M Trojano, G Izquierdo, ... Brain 136 (12), 3609-3617, 2013 | 206 | 2013 |
| Immune-mediated neurological syndromes in SARS-CoV-2-infected patients A Guilmot, S Maldonado Slootjes, A Sellimi, M Bronchain, B Hanseeuw, ... Journal of neurology 268, 751-757, 2021 | 203 | 2021 |
| Male sex is independently associated with faster disability accumulation in relapse-onset MS but not in primary progressive MS KA Ribbons, P McElduff, C Boz, M Trojano, G Izquierdo, P Duquette, ... PloS one 10 (6), e0122686, 2015 | 203 | 2015 |
| Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study T Kalincik, JWL Brown, N Robertson, M Willis, N Scolding, CM Rice, ... The Lancet Neurology 16 (4), 271-281, 2017 | 176 | 2017 |
| The leader protein of Theiler's virus inhibits immediate-early alpha/beta interferon production V Van Pesch, O van Eyll, T Michiels Journal of virology 75 (17), 7811-7817, 2001 | 148 | 2001 |
| Diagnosis and classification of optic neuritis A Petzold, CL Fraser, M Abegg, R Alroughani, D Alshowaeir, R Alvarenga, ... The Lancet Neurology 21 (12), 1120-1134, 2022 | 141 | 2022 |
| Paramagnetic rim lesions are specific to multiple sclerosis: an international multicenter 3T MRI study P Maggi, P Sati, G Nair, ICM Cortese, S Jacobson, BR Smith, A Nath, ... Annals of neurology 88 (5), 1034-1042, 2020 | 132 | 2020 |
| The leader protein of Theiler's virus interferes with nucleocytoplasmic trafficking of cellular proteins S Delhaye, V Van Pesch, T Michiels Journal of virology 78 (8), 4357-4362, 2004 | 132 | 2004 |
| Comparison of switch to fingolimod or interferon beta/glatiramer acetate in active multiple sclerosis A He, T Spelman, V Jokubaitis, E Havrdova, D Horakova, M Trojano, ... JAMA neurology 72 (4), 405-413, 2015 | 130 | 2015 |
| Towards personalized therapy for multiple sclerosis: prediction of individual treatment response T Kalincik, A Manouchehrinia, L Sobisek, V Jokubaitis, T Spelman, ... Brain 140 (9), 2426-2443, 2017 | 119 | 2017 |
